ASCRS $1 million better off

Article

Advanced Medical Optics (AMO) has pledged $1 million to support the American Society of Cataract and Refractive Surgery's (ASCRS) foundation sponsored research in the field of refractive lenticular science.

Advanced Medical Optics (AMO) has pledged $1 million to support the American Society of Cataract and Refractive Surgery's (ASCRS) foundation sponsored research in the field of refractive lenticular science.

The ASCRS Foundation funds ophthalmic research, public education and charitable activities in the developing world and in 2006 it is due to begin work on a multi-year programme supporting new research and educational programmes exploring the science of refractive lenticular surgery.

Re-brand for Ellex Medical Lasers

Ellex is to replace the brand "Laserex" and the company's US and Japanese subsidiaries will also adopt the name. The company is also due to relocate its global headquarters responsible for sales, marketing and customer services to San Francisco, US, in a move, that it says, will bring it closer to its three main markets of North America, North Asia and Europe. Ellex's manufacturing, engineering and finance operations will remain in Adelaide, Australia.

Ellex designs and manufactures various laser systems for the ophthalmic industry including photodisrupters, photocoagulators and selective laser trabeculoplasty systems.

Carl Zeiss Meditec to grow: not yet

At the company's fourth Annual General Meeting, more than 99% of the shareholders supported the initiative. Despite this broad approval, a small number lodged objections against the acquisition and all other items on the agenda. As a result, eight shareholders have now filed legal actions against the planned acquisition, which appears to have delayed the approval procedure. Nonetheless, Carl Zeiss Meditec's intention to acquire Carl Zeiss Surgical remains unchanged.

The acquisition is likely to make Carl Zeiss Meditec the third largest listed medical technology company in Germany.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.